Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ACVRL1,Serine/threonine-protein kinase receptor R3,17090,144,4.10 [2.60-6.47],1.4041967039674804e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,14610,113,2.87 [1.96-4.21],5.920655758209879e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,AGRN,Agrin,17322,144,2.10 [1.53-2.89],4.2713093207259504e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,AMBP,Protein AMBP,17376,145,7.62 [3.76-15.42],1.6676033229046984e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ANGPT2,Angiopoietin-2,17406,145,2.52 [1.77-3.58],2.796457129013795e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,AOC3,Membrane primary amine oxidase,17349,144,3.02 [1.88-4.86],5.408420671538637e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ASGR1,Asialoglycoprotein receptor 1,17120,144,2.66 [1.74-4.06],6.024301236998671e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ATRAID,All-trans retinoic acid-induced differentiation factor,14983,116,1.96 [1.59-2.41],2.0869294308554446e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,B4GALT1,"Beta-1,4-galactosyltransferase 1",17322,144,3.11 [1.91-5.07],5.507644236340139e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,BAMBI,BMP and activin membrane-bound inhibitor homolog,16864,142,2.93 [2.04-4.21],7.021064734596511e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,BSG,Basigin,17446,144,5.16 [2.64-10.09],1.5259944328448224e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,BST2,Bone marrow stromal antigen 2,17417,145,1.74 [1.38-2.19],2.697847787828016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,BTN2A1,Butyrophilin subfamily 2 member A1,17322,144,3.15 [2.00-4.96],6.947440554160285e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD27,CD27 antigen,17293,144,2.36 [1.78-3.15],3.482998407936625e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD300E,CMRF35-like molecule 2,17359,145,2.35 [1.71-3.22],1.288837387808957e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD302,CD302 antigen,17171,144,3.21 [2.24-4.61],2.2204307112299887e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD59,CD59 glycoprotein,16669,132,3.64 [2.27-5.86],9.257777521877286e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD74,HLA class II histocompatibility antigen gamma chain,17417,145,2.52 [1.71-3.70],2.63675253373626e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD79B,B-cell antigen receptor complex-associated protein beta chain,17475,146,2.04 [1.59-2.61],1.560839269834642e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD80,T-lymphocyte activation antigen CD80,15048,116,2.57 [1.71-3.87],6.2034483523715085e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CD83,CD83 antigen,17243,146,2.52 [1.74-3.65],1.0279226528166945e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,16647,140,1.70 [1.37-2.09],8.706015962424328e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",14988,115,2.89 [2.11-3.95],3.991600794727106e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CHGA,Chromogranin-A,15035,117,1.48 [1.26-1.74],1.4632473261323048e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CKAP4,Cytoskeleton-associated protein 4,17381,143,2.67 [1.96-3.63],3.3919291427242884e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CLEC14A,C-type lectin domain family 14 member A,17259,144,3.10 [2.04-4.71],1.0426360175218553e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CLEC1A,C-type lectin domain family 1 member A,16957,141,2.95 [1.99-4.38],8.499931475242468e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CLMP,CXADR-like membrane protein,17406,145,4.92 [2.62-9.21],6.620503974131451e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,COL6A3,Collagen alpha-3(VI) chain,17469,145,3.03 [2.16-4.25],1.4326314873306275e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,COLEC12,Collectin-12,17232,144,3.74 [2.31-6.07],8.05628203373445e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CSF1,Macrophage colony-stimulating factor 1,17322,144,3.22 [1.92-5.40],9.12468181097954e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CST3,Cystatin-C,17319,142,3.41 [2.21-5.25],2.6828551194156933e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CX3CL1,Fractalkine,17120,144,2.55 [1.79-3.63],2.501411288986515e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CXADR,Coxsackievirus and adenovirus receptor,17243,146,1.87 [1.43-2.45],3.934450027210267e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,CYTL1,Cytokine-like protein 1,15035,117,3.84 [2.12-6.93],8.41709342995691e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,DCN,Decorin,16957,141,4.73 [2.63-8.51],2.2515077464420961e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,DLL1,Delta-like protein 1,17293,144,3.44 [2.20-5.38],6.639994959417356e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EDA2R,Tumor necrosis factor receptor superfamily member 27,17406,145,3.61 [2.72-4.79],6.728875270420308e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EFCAB14,EF-hand calcium-binding domain-containing protein 14,14983,116,1.83 [1.43-2.34],2.0376758402634383e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EFNA1,Ephrin-A1,17228,144,2.92 [1.89-4.51],1.3148014423540918e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EFNA4,Ephrin-A4,17090,144,3.54 [2.60-4.83],9.564701668541066e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EPHA2,Ephrin type-A receptor 2,16616,140,4.20 [2.76-6.39],2.31348211324232e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EPHB4,Ephrin type-B receptor 4,17469,145,3.54 [2.07-6.08],4.294882126755577e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,EPHB6,Ephrin type-B receptor 6,17095,144,2.67 [1.76-4.07],4.588962903761328e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,FABP1,"Fatty acid-binding protein, liver",17232,144,1.47 [1.28-1.69],6.539446951975885e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,FAM3C,Protein FAM3C,17213,143,3.22 [2.01-5.15],1.1403578579159823e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,FBLN2,Fibulin-2,15035,117,2.92 [1.82-4.69],8.784784546165629e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,FGF23,Fibroblast growth factor 23,17374,144,1.57 [1.29-1.90],4.519335560207164e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,17120,144,2.91 [1.87-4.52],1.966898509347983e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,FSTL3,Follistatin-related protein 3,17207,144,3.24 [2.17-4.85],1.0397446932281166e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,GDF15,Growth/differentiation factor 15,17469,145,2.78 [2.19-3.54],5.687505258243869e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,GFRA1,GDNF family receptor alpha-1,17384,144,3.74 [2.33-6.01],5.010127788730506e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,GGT5,Glutathione hydrolase 5 proenzyme,17120,144,3.31 [2.05-5.35],9.586382661401134e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,GUCA2A,Guanylin,17167,144,2.42 [1.65-3.53],4.914906829961572e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,HAVCR1,Hepatitis A virus cellular receptor 1,17376,145,1.79 [1.45-2.20],5.6076346869346e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",17243,146,2.96 [1.95-4.50],3.838916672217783e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,14620,117,2.31 [1.70-3.13],8.614374208123891e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,HSPB6,Heat shock protein beta-6,17406,145,2.45 [1.79-3.36],2.311169259433345e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,17140,142,3.65 [2.46-5.41],1.0606633852333575e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,IFNGR1,Interferon gamma receptor 1,17322,144,2.89 [1.94-4.30],1.762705046639263e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,IGFBP4,Insulin-like growth factor-binding protein 4,17055,144,2.39 [1.85-3.08],1.9125541269817327e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,IGFBP6,Insulin-like growth factor-binding protein 6,17202,143,2.74 [1.90-3.97],8.099175833089736e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,IL10RB,Interleukin-10 receptor subunit beta,17322,144,2.32 [1.65-3.25],1.067277789197241e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,IL18BP,Interleukin-18-binding protein,17349,144,3.10 [2.09-4.61],2.1034297281053572e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,JAM2,Junctional adhesion molecule B,17417,145,3.42 [2.13-5.49],3.3723624988792025e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,KLK11,Kallikrein-11,17109,142,1.91 [1.49-2.45],3.384304824132097e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,KLK4,Kallikrein-4,17406,145,1.68 [1.40-2.00],1.2268906758537465e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,17232,144,1.96 [1.52-2.51],1.3729419612224854e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LAYN,Layilin,17095,144,3.45 [2.45-4.85],9.66474932639881e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LGALS4,Galectin-4,17232,144,1.72 [1.36-2.19],7.417770919267366e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LIFR,Leukemia inhibitory factor receptor,17243,146,3.30 [1.95-5.58],8.269491748021482e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,16979,142,2.12 [1.55-2.90],2.279650920112939e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LMOD1,Leiomodin-1,15011,115,2.13 [1.58-2.87],5.992905969145076e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LTBP2,Latent-transforming growth factor beta-binding protein 2,17469,145,3.08 [2.06-4.61],4.2179138664305376e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LTBR,Tumor necrosis factor receptor superfamily member 3,17134,143,3.16 [2.07-4.82],9.817377598311477e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,LY6D,Lymphocyte antigen 6D,17145,142,1.96 [1.47-2.63],6.322317468705434e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,MERTK,Tyrosine-protein kinase Mer,17475,146,3.75 [2.17-6.47],2.151806252449067e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,MMP12,Macrophage metalloelastase,17269,143,1.96 [1.53-2.52],1.297894094531455e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,MMP7,Matrilysin,16934,141,2.51 [1.84-3.42],5.571246232681279e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NBL1,Neuroblastoma suppressor of tumorigenicity 1,17293,144,3.68 [2.18-6.19],9.98535997517488e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NCS1,Neuronal calcium sensor 1,17406,145,3.33 [2.07-5.37],7.558322050146581e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NECTIN4,Nectin-4,17293,144,2.70 [1.89-3.84],3.90752856204336e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NEFL,Neurofilament light polypeptide,16853,141,2.52 [2.03-3.14],9.786480586973459e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NPC2,NPC intracellular cholesterol transporter 2,14787,115,2.20 [1.59-3.03],1.5263676240593416e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NPDC1,Neural proliferation differentiation and control protein 1,17236,143,2.47 [1.79-3.42],4.4262027320959016e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NPPB,Natriuretic peptides B,16957,141,1.30 [1.16-1.45],4.572117032983269e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,NT5C1A,Cytosolic 5'-nucleotidase 1A,14988,115,2.12 [1.57-2.87],1.1838163925875825e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,OGN,Mimecan,17259,144,2.64 [1.95-3.58],3.910727062335356e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PALM2,Paralemmin-2,14988,115,3.23 [2.20-4.73],1.797250909749335e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PDCD1LG2,Programmed cell death 1 ligand 2,17171,144,2.85 [1.88-4.31],7.38695447673204e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PENK,Proenkephalin-A,14711,112,3.04 [1.90-4.86],3.549511297503094e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PGF,Placenta growth factor,17475,146,3.18 [2.23-4.54],1.5301930205414918e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,17259,144,3.02 [1.98-4.61],2.693447005911963e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PLAUR,Urokinase plasminogen activator surface receptor,17109,142,3.60 [2.21-5.84],2.3971030227036906e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,PTGDS,Prostaglandin-H2 D-isomerase,17146,143,2.48 [1.72-3.57],1.0415242933389142e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,RBFOX3,RNA binding protein fox-1 homolog 3,15011,115,2.34 [1.83-2.99],1.5142770038021808e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,REG1A,Lithostathine-1-alpha,17185,144,1.83 [1.45-2.31],3.030442851139508e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,REG3A,Regenerating islet-derived protein 3-alpha,17469,145,1.72 [1.42-2.08],3.588841075593892e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,REG4,Regenerating islet-derived protein 4,17262,144,2.06 [1.58-2.69],8.800895938340585e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,RELT,Tumor necrosis factor receptor superfamily member 19L,17259,144,3.12 [2.10-4.64],2.055716606692032e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,REN,Renin,17236,143,1.61 [1.39-1.87],2.753743704326901e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,RSPO3,R-spondin-3,17406,145,3.71 [2.50-5.52],9.527255271023002e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SCARB2,Lysosome membrane protein 2,16775,142,3.37 [2.47-4.59],1.2619336360798944e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SCARF2,Scavenger receptor class F member 2,17417,145,3.40 [2.06-5.61],1.6107699451239993e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SFRP1,Secreted frizzled-related protein 1,17058,144,1.85 [1.43-2.41],3.429446213170685e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SHISA5,Protein shisa-5,15035,117,2.73 [2.11-3.52],1.4127012243562992e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SMOC1,SPARC-related modular calcium-binding protein 1,17406,145,2.47 [1.80-3.38],2.401860340994145e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SPINK1,Serine protease inhibitor Kazal-type 1,17259,144,2.34 [1.72-3.17],4.335105745416739e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SPINK4,Serine protease inhibitor Kazal-type 4,17243,146,1.59 [1.31-1.93],2.5991031146032627e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,SPON1,Spondin-1,17262,144,2.84 [1.94-4.16],7.932005814971226e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TFF2,Trefoil factor 2,17295,144,1.68 [1.34-2.11],8.381218301537757e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TFF3,Trefoil factor 3,17284,141,2.39 [1.92-2.98],1.0511001065943124e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TGFBR2,TGF-beta receptor type-2,17293,144,3.06 [2.26-4.14],3.9951036351345563e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,THBD,Thrombomodulin,17236,143,2.46 [1.69-3.58],2.3770094223438348e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,17120,144,2.17 [1.67-2.82],6.076590292602199e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,17120,144,1.46 [1.25-1.70],9.262033687139492e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,17475,146,3.00 [2.22-4.07],1.2261675831367974e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,17293,144,2.85 [2.08-3.89],4.802672392785036e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,17262,144,2.73 [1.79-4.15],2.904313060807729e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,17406,145,3.47 [2.52-4.77],2.4762583221371143e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,17259,144,3.24 [2.20-4.78],2.863257310848823e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,17259,144,1.86 [1.48-2.33],7.554911333043415e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,17446,144,2.29 [1.66-3.18],5.77619936653205e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,17120,144,1.79 [1.43-2.23],2.3170975939783057e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,TPM3,Tropomyosin alpha-3 chain,14531,113,1.88 [1.45-2.43],1.955888224172235e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,ULBP2,UL16-binding protein 2,17120,144,2.52 [1.81-3.50],3.942369613152305e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,VCAM1,Vascular cell adhesion protein 1,17324,144,3.24 [2.10-5.02],1.2287330135393962e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,VSIG4,V-set and immunoglobulin domain-containing protein 4,17239,144,2.19 [1.56-3.06],5.158948333745742e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,WFDC2,WAP four-disulfide core domain protein 2,16408,132,2.66 [2.04-3.47],5.285062770366726e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,WNT9A,Protein Wnt-9a,16979,142,3.01 [2.21-4.10],2.511398039795044e-12
